Telesis Bio Net Tangible Assets

Telesis Bio (TBIO) currently reports a net tangible assets of $3.9M as of September 2024. That compares with $46M in the prior-year period — down 91.7% year over year. Use the charts on this page to explore Telesis Bio's net tangible assets history and peer comparisons.

Telesis Bio's net tangible assets decreased from $46M to $3.9M — a 91.7% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Telesis Bio reported $3.9M in net tangible assets as of September 2024. That compares with $46M in the prior-year period — down 91.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $3.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Telesis Bio, and consider following TBIO for alerts when major investors trade the stock.

Telesis Bio is classified in the Healthcare sector. On net tangible assets, it currently shows $3.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TBIO with unrelated industries.